Anti-obesity effects of α-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

Nature Medicine

Volumn 10, Issue 7, 2004, Pages 727-733

  Kim, Min Seon ^a   Park, Joong Yeol ^a   Namkoong, Cherl ^a   Jang, Pil Geum ^a   Ryu, Je Won ^a   Song, Hai Sun ^a   Yun, Ji Young ^a   Namgoong, Il Seong ^a   Ha, Joohun ^b   Park, In Sun ^c   Lee, In Kyu ^d   Viollet, Benoit ^e   Youn, Jang Hyun ^f   Lee, Hong Kyu ^g   Lee, Ki Up ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

^c Inha University School of Medicine   (South Korea)

^d Keimyung University School of Medicine   (South Korea)

^e INSTITUT COCHIN   (France)

^f UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^g Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; THIOCTIC ACID;

ANIMAL CELL; ARTICLE; BRAIN MITOCHONDRION; CELL ENERGY; CONTROLLED STUDY; ENERGY EXPENDITURE; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; HYPERPHAGIA; HYPOTHALAMUS; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; BODY WEIGHT; CYCLIC AMP-DEPENDENT PROTEIN KINASES; EATING; ENERGY METABOLISM; ENZYME ACTIVATION; HYPOTHALAMUS; LEPTIN; MICE; MUSCLE, SKELETAL; RATS; THIOCTIC ACID;

ANIMALIA; RODENTIA;

EID: 3142677140     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1061     Document Type: Article

References (36)

1. Halaas, J.L. et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269, 543-546 (1995).
2. Woods, S.C., Lotter, E.C., McKay, L.D. & Porte, D. Jr. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons. Nature 282, 503-505 (1979).
3. Obici, S. et al. Central administration of oleic acid inhibits glucose production and food intake. Diabetes 51, 271-275 (2002).
4. Davis, J.D., Wirtshafter, D., Asin, K.E. & Brief, D. Sustained intracerebroventricular infusion of brain fuels reduces body weight and food intake in rats. Science 212, 81-83 (1981).
5. Hardie, D.G. & Carling, D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur. J. Biochem. 246, 259-273 (1997).
6. Hayashi, T. et al. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 49, 527-531 (2000).
7. Ruderman, N.B., Saha, A.K., Vavvas, D. & Witters, L.A. Malonyl-CoA, fuel sensing, and insulin resistance. Am. J. Physiol. 276, E1-E18 (1999).
8. Turnley, A.M. et al. Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system. J. Neurochem. 72, 1707-1716 (1999).
9. Andersson, U. et al. AMP-activated protein kinase plays a role in the control of food intake. J. Biol. Chem. 279, 12005-12008 (2004).
10. Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569-574 (2004).
11. Ziegler, D. et al. Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study). Diabetologia 38, 1425-1433 (1995).
12. Jacob, S. et al. The antioxidant α-lipoic acid enhances insulin-stimulated glucose metabolism in insulin-resistant rat skeletal muscle. Diabetes 45, 1024-1029 (1996).
13. Benoit, S.C. et al. Assessment of the aversive consequences of acute and chronic administration of the melanocortin agonist, MTII. Int. J. Obes. Relat. Metab. Disord. 27, 550-556 (2003).
14. Dalgaard, L.T. & Pedersen, O. Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44, 946-965 (2001).
15. Schwartz, M.W., Woods, S.C., Porte, D. Jr., Seeley, R.J. & Baskin, D.G. Central nervous system control of food intake. Nature 404, 661-671 (2000).
16. Obici, S., Feng, Z., Arduini, A., Conti, R. & Rossetti, L. Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production. Nat. Med. 9, 756-761 (2003).
17. Woods, A. et al. Characterization of the role of AMP-activated protein kinase in the regulation of glucose-activated gene expression using constitutively active and dominant negative forms of the kinase. Mol. Cell. Biol. 20, 6704-6711 (2000).
18. Hagen, T.M. et al. (R)-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J. 13, 411-418 (1999).
19. Zimmer, G., Mainka, L. & Kruger, E. Dihydrolipoic acid activates oligomycin-sensitive thiol groups and increases ATP synthesis in mitochondria. Arch. Biochem. Biophys. 288, 609-613 (1991).
20. Yaworsky, K., Somwar, R., Ramlal, T., Tritschler, H.J. & Klip, A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by α-lipoic acid in 3T3-L1 adipocytes. Diabetologia 43, 294-303 (2000).
21. Smith, G.P. & Epstein, A.N. Increased feeding in response to decreased glucose utilization in the rat and monkey. Am. J. Physiol. 217, 1083-1087 (1969).
22. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (2001).
23. Loftus, T.M. et al. Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. Science 288, 2379-2381 (2000).
24. Brown, N.F., Esser, V., Foster, D.W. & McGarry, J.D. Expression of a cDNA for rat liver carnitine palmitoyltransferase I in yeast establishes that catalytic activity and malonyl-CoA sensitivity reside in a single polypeptide. J. Biol. Chem. 269, 26438-26442 (1994).
25. Commins, S.P., Watson, P.M., Levin, N., Beiler, R.J. & Gettys, T.W. Central leptin regulates the UCP1 and ob genes in brown and white adipose tissue via different β-adrenoceptor subtypes. J. Biol. Chem. 275, 33059-33067 (2000).
26. Henriksen, E.J. et al. Stimulation by α-lipoic acid of glucose transport activity in skeletal muscle of lean and obese Zucker rats. Life Sci. 61, 805-812 (1997).
27. Minokoshi, Y. et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415, 339-343 (2002).
28. Niimi, M., Sato, M., Yokote, R., Tada, S. & Takahara, J. Effects of central and peripheral injection of leptin on food intake and on brain Fos expression in the Otsuka Long-Evans Tokushima Fatty rat with hyperleptinaemia. J. Neuroendocrinol. 11, 605-611 (1999).
29. Maffei, M. et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155-1161 (1995).
30. Kim, M.S. et al. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin. J. Clin. Invest. 105, 1005-1011 (2000).
31. Ryu, J.W. et al. DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats. Biochem. Biophys. Res. Commun. 303, 726-731 (2003).
32. Tritos, N.A., Elmquist, J.K., Mastaitis, J.W., Flier, J.S. & Maratos-Flier, E. Characterization of expression of hypothalamic appetite-regulating peptides in obese hyperleptinemic brown adipose tissue-deficient (uncoupling protein-promoter-driven diphtheria toxin A) mice. Endocrinology 139, 4634-4641 (1998).
33. Dyck, J.R. et al. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic β and γ subunits. J. Biol. Chem. 271, 17798-17803 (1996).
34. Morton, G.J. et al. Arcuate nucleus-specific leptin receptor gene therapy attenuates the obesity phenotype of Koletsky (fak/fak) rats. Endocrinology 144, 2016-2024 (2003).
35. Mercer, E.H., Hoyle, G.W., Kapur, R.P., Brinster, R.L. & Palmiter, R.D. The dopamine β-hydroxylase gene promoter directs expression of E. coli lacZ to sympathetic and other neurons in adult transgenic mice. Neuron 7, 703-716 (1991).
36. Lee, Y. et al. Increased lipogenic capacity of the islets of obese rats. Diabetes 46, 408-413 (1997).